<DOC>
	<DOCNO>NCT00566566</DOCNO>
	<brief_summary>Background : Acute Lymphoblastic Leukemia ( ALL ) common malignancy child . It account 25 % childhood cancer . Peak incidence occur 2 5 year age . Modern treatment regimens improved cure rate virtually zero ( 1950 's ) current overall survival rate approximately 80 % .The high survival rate introduce u novel medical problem consequence different treatment regimen . No single treatment modality exist today rather several treatment protocol accept worldwide . As , population childhood ALL survivor differ toxic exposure : cranial &amp; spinal radiotherapy , intrathecal and/or systemic chemotherapy bone marrow transplantation .As survival rate grow , young adult ALL survivor worldwide susceptible late effect treatment . Numerous report point particular group increase risk develop cardiovascular disease ( CVD ) diabetes ( MS ) . The metabolic syndrome , i.e hypertension , dyslipidemia , impair glucose metabolism obesity , occur young age general population . Adipocytokines , mediator secrete adipose tissue , play important role regulation carbohydrates lipid metabolism.Changes serum adipokine level precede clinical symptom . We aim identify assess prevalence MS ALL survivor . We aim characterize population risk develop DM CVD prior overt clinical disease . Characterization do measure serum adipocytokines inflammatory cytokine profile .Biochemical characterization group risk enable u intervene preventive stage future .</brief_summary>
	<brief_title>Adipokines Predictors Metabolic Syndrome ALL Survivors</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<criteria>ALL diagnosis five year completion treatment leukemia free research ongoing chemotherapy radiotherapy</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2007</verification_date>
	<keyword>adipocytokines</keyword>
	<keyword>inflammatory marker</keyword>
	<keyword>cardiovascular disease</keyword>
	<keyword>diabetes mellitus</keyword>
	<keyword>Leptin</keyword>
</DOC>